Systems Oncology is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance. 

Biotechnology

Systems Oncology

Spyro Mousses

Katy Marhenke

Robert G. Petit II

Lizette Castano

Marvin O’Ketch

Andrew Matricaria

Gavin Bogle

David Azorsa

David Lee

Jeff Kiefer

Daniel D. Von Hoff

The leadership team at Systems Oncology has a history of experience in various industries and fields of study. Many of the team members have worked as instructors at universities, while others have experience in business and finance. Additionally, many on the team have experience in research and development in fields such as biochemistry, pharmacology, and applied mathematics.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Systems Oncology

Board of Directors

CEO and Executive Team